We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Alternative for Treating Hip Fractures

By HospiMedica staff writers
Posted on 30 Jul 2007
A new technology to treat intertrochanteric hip fractures spares muscle tissue and enhances fixation, even in osteoporotic patients.

The Peak FxT system boasts a unique plate design with a low-profile tapered plate and an instrument design that allows insertion into tissues without undue trauma to surrounding muscles. More...
A lag screw features a blunt nose, plateau-style thread design and a self-tapping feature designed for optimum fixation to the femoral head, addressing the need for stability and fixation, even in osteoporotic patients. The plate can be used with traditional surgical or with minimally invasive techniques. The surgical instruments used with the system have been modified to reduce time and simplify the procedure.

The Peak FxT Hip Plate is available with a controlled-collapse mechanism, a technology that addresses the clinical issue of proximal femoral offset loss and excess collapse, which are typical of traditional hip screw devices. The lag-screw assembly also reduces the risk of implant disassociation in both the medial and lateral directions. Another feature is an integrated keying mechanism that provides the option of rotationally locking the lag screw without sacrificing tip-apex distance or final plate placement, which may simplify the surgical technique. ThePeak FxT system is a product of DePuy Orthopaedics (Warsaw, IN, USA).

"Given how much a hip fracture affects a patient's life, our goal with this new technology is to repair the fracture while sparing the surrounding tissues as much as possible to leave the muscles as strong as they can be to support optimum recovery and rehabilitation, said Richard Kyle, M.D., director of orthopedics at Hennepin County medical center (Minneapolis, MN, USA). "By sparing more of the crucial tissues and vessels near the fracture, the new system provides surgeons with a modern alternative to nails and other devices.”


Related Links:
DePuy Orthopaedics

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.